RCP members vote to limit physician associate roles amid calls for president to resign
BMJ 2024; 384 doi: https://doi.org/10.1136/bmj.q732 (Published 25 March 2024) Cite this as: BMJ 2024;384:q732Members and fellows of the Royal College of Physicians (RCP) have voted overwhelmingly to limit the pace and scale of the rollout of physician associates (PAs)—a result that has exposed a rift between grassroot doctors and the college and led to calls for the resignation of its president.
On 13 March a fractious extraordinary general meeting (EGM) was held to debate matters relating to PAs. Members and fellows expressed concern that RCP had presented data from a members’ survey about PAs in a biased way.1
RCP hosts the Faculty of Physician Associates and receives membership and examination fees from PAs.
Voting on five motions closed on 20 March and the college said because of the importance of the ballot they had decided to release the results immediately, instead of 25 March as planned. Four motions covering PAs scope of practice, accountability, evaluation, and impact on training opportunities were passed with between 95.6% and 96.9% of the vote.
The controversy centred on the fifth motion which read, “In the initial request for the EGM, fellows called on RCP to pause the rollout of PA roles. A pause is clearly not feasible given recent legislation. This EGM therefore calls on RCP to limit the pace and scale of the rollout until the medicolegal matters of regulation, standards, and scope of practice are tackled.” The motion was passed with 78.7% of the vote.
The turnout for the ballot was 31% and the number of votes cast was 4398.
RCP president Sarah Clarke said, “RCP will now work closely with its council, board of trustees, and key stakeholders in response to this clear direction from the fellowship.”
Anger from members
Palliative care doctor Rachel Clarke said the result shows “the severity of the disconnect between RCP leadership and the members and fellows that those leaders purport to represent.” She told The BMJ, “The college has failed to read the room from the outset, grossly underestimating both the strength of members’ concerns around PAs and our incredulity at college conduct during the EGM.”
Clarke had been so upset by the EGM that she has decided no longer to be a keynote speaker at this year’s RCP annual conference. “Even now, the college has failed to apologise for misrepresenting data from the members’ survey, referring only to ‘confusion’ around how they chose to present the data, rather than what actually occurred—namely a deliberate attempt to cover up members’ negative views of PAs by conflating ‘neutral’ and ‘positive’ responses,” she said.
“This is a probity matter—a clear attempt to gerrymander a democratic vote. If a drug company rather than a royal college had misrepresented data in this way, it would be nothing less than a scandal. I can only imagine the interest the General Medical Council would be taking if it were an individual doctor at fault.”
Clarke said she could not see how Sarah Clarke could remain as president of RCP. “The data misrepresentation alone is disastrous—but the PA project she is spearheading has now been proven to be radically at odds with the views of members. She does not represent us, and neither, I believe, does the college currently meet the high standards of professionalism and probity the public rightly expects from all doctors.”
Trish Greenhalgh, professor of general practice at the Nuffield Department of Primary Care Health Sciences at the University of Oxford, said, “I have been shocked at the unfolding of what I interpret to be serious breaches of governance at the heart of the college, and with the degree to which senior officers have shown themselves to be out of touch with the clinical professionals they are in post to serve.”
She told The BMJ, “I remain concerned that the partial and distorted presentation of data at the EGM may have been a deliberate attempt to deceive. I understand there is to be an independent inquiry and I hope this will be the start of a transformation for the better in college leadership.”
Mamas Mamas, interventional cardiologist at Keele University, wrote on X, “Despite the best efforts of senior leaders of RCP to define what we were allowed to vote on, sabotage the open debate at EGM, and misrepresent data, the fellows of the royal college have spoken and highlighted their views on the unregulated mess of PAs in the NHS. The current leadership has lost the support of their members and in view of this overwhelming mandate should resign.”2
Partha Kar, consultant in diabetes and endocrinology at Portsmouth Hospitals NHS Trust, welcomed the fact that the fellowship had resoundingly passed all five motions. Kar said, “It is time now for senior leadership to reflect on the result, listen to their members, and work on matters regarding PAs, especially around safety, presence on rotas, and development of scope. A pause is the right thing for many reasons—most importantly to take stock of this healthcare intervention and review it in light of patient safety flags.”
There are around 3000 PAs currently working in the UK. NHS England’s long term workforce plan aims for an expansion in numbers over the next decade.
RCP president Sarah Clarke recently wrote an opinion piece for The BMJ arguing there is a role for PAs in the NHS. She was asked by The BMJ to update her competing interests statement so that it now states that RCP hosts the Faculty of Physician Associates and receives membership and examination fees from PAs. The college therefore risks a financial loss from a limit in the rollout of PAs.3
The BMA recently published guidance stating that PAs should be barred from diagnosing or from claiming to be “one of the medical team” without stating their job title.4
The Royal College of General Practitioners recently shifted its position on PAs after members of its UK council passed a motion stating that “another regulatory body would be more appropriate to take this crucial work forward to regulate PAs.”5
In October last year members of the Royal College of Anaesthetists voted through six resolutions proposed by grassroots campaigners who opposed the expansion of anaesthesia associates, in an extraordinary general meeting.6
On 21 March, the British Association of Oral and Maxillofacial Surgery released a position statement saying their council unanimously agrees that there is no role for PAs in the practice of oral and maxillofacial surgery.7
Motions passed at RCP extraordinary general meeting on matters relating to PAs
Motion 1 on scope of practice was passed with 96.9% of the vote
Motion 2 on accountability was passed with 95.6% of the vote
Motion 3 on evaluation was passed with 96.1% of the vote
Motion 4 on training opportunities was passed with 95.9% of the vote
Motion 5 on caution in pace and scale of rollout was passed with 78.7% of the vote